Riskpilot← Back to searchSign inGet full accessCOLOSSEUM ØYELEGESENTER AS
ASActiveOrg 985245789Sørkedalsveien 10, 0369 OsloMedical specialists activities · NACE 8622Est. 200313 employees
Revenue 2024
NOK 6,5M
-6% vs 2023
EBITDA margin
0.1%
-39% vs 2023
Equity ratio
6.4%
Financial strength
Net profit 2024
NOK 73
+102% vs 2023
| Revenue | NOK 6,5M | -6% |
| EBITDA | NOK 5K | -39% |
| Net profit | NOK 73 | +102% |
| Total assets | NOK 1,7M | -3% |
| Equity | NOK 111K | +0% |
| Employees | 13 | — |
Legal name
COLOSSEUM ØYELEGESENTER AS
Org number
985245789
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
9. januar 2003
Share capital
NOK 102 000
Employees
13 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Utføre virksomhet ved administrasjon av colosseum øyelegesenter as, andre tilsvarende sentra, konsulenttjenester og annen virksomhet som tilligger dette.
Address
Sørkedalsveien 10, 0369 Oslo
Phone
+4723201180
Email
post@colos.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 708 | 6 561 | 7 254 | 6 978 | 6 538 |
| Staff expenses | −2 390 | −2 920 | −3 062 | −2 907 | −2 904 |
| EBITDA | 133 | −4 | 26 | 8 | 5 |
| Depreciation & amort. | −62 | −57 | −54 | −18 | −18 |
| EBIT | 71 | −62 | −28 | −10 | −13 |
| Net financials | −71 | 0 | 1 | 6 | 13 |
| Profit before tax | 0 | −62 | −27 | −3 | 0 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | −62 | −27 | −3 | 0 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 861 | 1 986 | 1 521 | 1 780 | 1 730 |
| Equity | 203 | 142 | 114 | 111 | 111 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 658 | 1 844 | 1 406 | 1 669 | 1 619 |
| Total debt | 1 658 | 1 844 | 1 406 | 1 669 | 1 619 |
EBITDA margin
0.1%
This company
15.8%
Market median
-99% vs market
20202024
Equity ratio
6.4%
This company
38.2%
Market median
-83% vs market
20202024
Return on equity
0.1%
This company
18.4%
Market median
-99% vs market
20202024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
3.78×
This company
1.12×
Market median
+237% vs market
20202024
Debt / equity
14.57×
This company
0.62×
Market median
-2250% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LB Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Former (4) | ||
| Board of Directors | 2019 – 2021 | |
| Chairman | 2021 – 2022 | |
| Board of Directors | 2022 – 2022 | |
| Board of Directors | 2019 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33.33% | 33.33% | 2024 | |
| Company | 33.33% | 33.33% | 2024 | |
| Company | 33.33% | 33.33% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Øyvind Osnes-Ringen As
COLOSSEUM ØYELEGESENTER AS Board members of COLOSSEUM ØYELEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Birger Bakke | Chief Executive Officer | 0 companies |
| Karin Cecilie Matheson Seem | Board of Directors | 0 companies |
| Øyvind Osnes-Ringen | Board of Directors | 0 companies |
| Espen Finnøy Bakke | Chairman | 0 companies |
| Per Geir Jansen | Chairman | 0 companies |
| Sidsel Gedde-Dahl Alme | Board of Directors | 0 companies |
| Gunnar Alme | Board of Directors | 0 companies |